HQ Function

The headquarters serves as the central hub for PliantRx's research and development operations, clinical trial management, and corporate administration.

Notable Features:

Located within uCity Square, a dynamic innovation campus in Philadelphia, offering access to a rich ecosystem of life science companies, research institutions, and talent.

Work Culture:

As a clinical-stage biopharmaceutical company, the work culture is likely to be research-intensive, innovative, collaborative, and fast-paced, with a strong focus on scientific rigor and achieving clinical milestones.

HQ Significance:

The Philadelphia location, particularly uCity Square, is significant for its concentration of biomedical research, offering PliantRx strategic advantages in collaboration, talent acquisition, and access to cutting-edge facilities.

Values Reflected in HQ: The choice of location in a prominent innovation district reflects values of scientific excellence, collaboration, and commitment to advancing medical treatments.

Location:

As a US-based clinical-stage company founded in 2023, PliantRx's primary operational presence is concentrated in the United States. Global activities would typically involve collaborations for clinical trials, which can span multiple countries, and potential future partnerships for drug development and commercialization. Specific international offices are not publicly documented.

Street Address:

3675 Market Street, Suite 200

City:

Philadelphia

State/Province:

PA

Country:

USA